| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 22,698 | 23,101 | 31,808 | 25,090 | | Cost of Revenue | 14,893 | 14,526 | 24,074 | 17,232 | | | Gross Profit | 7,805 | 8,575 | 7,734 | 7,858 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,898 | 9,037 | 9,702 | 11,505 | | Non Recurring | (752) | 108 | 644 | (1,138) | | Others | 1,114 | 1,262 | 997 | 1,036 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,455) | (1,832) | (3,609) | (3,545) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (194) |
-
| 70 | | Earnings Before Interest And Taxes | (2,168) | (2,026) | (3,609) | (3,475) | | Interest Expense |
-
| (179) | 179 | (13) | | Income Before Tax | (2,168) | (1,847) | (3,788) | (3,462) | | Income Tax Expense | (18) | 16 | 18 | (61) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,150) | (1,863) | (3,806) | (3,401) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| (748) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,150) | (1,863) | (3,806) | (4,149) | | Preferred Stock And Other Adjustments | (322) | (324) | (323) | (323) | | | Net Income Applicable To Common Shares | ($2,472) | ($2,187) | ($4,129) | ($4,472) |
|
0.51% Nasdaq 
Income Statement
